The UK quality and outcomes framework pay-for-performance scheme and spirometry: rewarding quality or just quantity? A cross-sectional study in Rotherham, UK by Strong, M. et al.
BioMed CentralBMC Health Services Research
ssOpen AcceResearch article
The UK Quality and Outcomes Framework pay-for-performance 
scheme and spirometry: rewarding quality or just quantity? A 
cross-sectional study in Rotherham, UK
Mark Strong*1,3, Gail South2 and Robin Carlisle3
Address: 1School of Health and Related Research, University of Sheffield, Regent Court, Sheffield, S1 4DA, UK, 2Breathing Space Primary Care 
Respiratory Centre, Badsley Moor Lane, Rotherham, S65 2QL, UK and 3Rotherham Primary Care Trust, Oak House, Moorhead Way, Rotherham, 
S66 1YY, UK
Email: Mark Strong* - m.strong@sheffield.ac.uk; Gail South - gail.south@rotherhampct.nhs.uk; 
Robin Carlisle - robin.carlisle@rotherhampct.nhs.uk
* Corresponding author    
Abstract
Background: Accurate spirometry is important in the management of COPD. The UK Quality
and Outcomes Framework pay-for-performance scheme for general practitioners includes
spirometry related indicators within its COPD domain. It is not known whether high achievement
against QOF spirometry indicators is associated with spirometry to BTS standards.
Methods: Data were obtained from the records of 3,217 patients randomly sampled from 5,649
patients with COPD in 38 general practices in Rotherham, UK. Severity of airflow obstruction was
categorised by FEV1 (% predicted) according to NICE guidelines. This was compared with clinician
recorded COPD severity. The proportion of patients whose spirometry met BTS standards was
calculated in each practice using a random sub-sample of 761 patients. The Spearman rank
correlation between practice level QOF spirometry achievement and performance against BTS
spirometry standards was calculated.
Results: Spirometry as assessed by clinical records was to BTS standards in 31% of cases (range
at practice level 0% to 74%). The categorisation of airflow obstruction according to the most recent
spirometry results did not agree well with the clinical categorisation of COPD recorded in the
notes (Cohen's kappa = 0.34, 0.30 – 0.38). 12% of patients on COPD registers had FEV1 (%
predicted) results recorded that did not support the diagnosis of COPD. There was no association
between quality, as measured by adherence to BTS spirometry standards, and either QOF COPD9
achievement (Spearman's rho = -0.11), or QOF COPD10 achievement (rho = 0.01).
Conclusion: The UK Quality and Outcomes Framework currently assesses the quantity, but not
the quality of spirometry.
Background
Good quality management of chronic obstructive pulmo-
nary disease (COPD) requires the use of spirometry for
diagnosis, staging and ongoing monitoring[1]. Spirome-
try can be undertaken successfully in primary care if staff
are appropriately trained[2]. However, poorly performed
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misclassification of the severity of airflow obstruction,
and lead to inappropriate therapy and unnecessary
patient anxiety[3].
Chronic obstructive pulmonary disease is included as a
clinical domain within the pay-for-performance UK gen-
eral practitioner "Quality and Outcomes Framework"
(QOF) contract, first introduced in 2004. The explicit aim
of QOF is to "reward contractors for good practice
through participation in an annual quality improvement
cycle"[4]. During the period of our study practices were
paid through the contract for holding a COPD register,
confirming the diagnosis of COPD with spirometry,
recording FEV1, checking inhaler technique and offering
flu vaccination.
GP practices have achieved highly on QOF COPD criteria.
Across England 96.0% of available COPD points were
obtained in the financial year 2006–7, worth approxi-
mately £33.5 million in incentive payments[5]. In Rother-
ham, the achievement was 94.5% of available points, and
resulted in the allocation of approximately £220,000 of
local NHS resources. This high level of achievement could
be seen as an indication that the quality of care for people
with COPD in English general practice is high. However,
this conclusion can only be drawn if QOF does indeed
measure "quality". A study conducted in Wales in the year
preceding the introduction of the contract found that in
approximately two fifths of the practices with spirometers,
staff were not confident in their use[6], suggesting that
universally high quality spirometry may have been diffi-
cult to achieve in the first years of the contract. This study
assesses the quality of spirometry in primary care in
Rotherham against evidence based standards published in
national guidance documents, and measures the associa-
tion between this measure of quality and QOF achieve-
ment at a practice level.
Methods
Sample
We obtained a register of all patients with a coded diagno-
sis of COPD from each of the 39 general practices in
Rotherham Primary Care Trust (PCT). One small special-
ist practice that provides care to Rotherham's asylum
seeker and homeless population had no patients coded as
having COPD and was therefore removed from the study.
In the remaining 38 practices we created two levels of
sample. Firstly, a larger sample was used to record the pro-
portions of patients categorised as having mild, moderate
or severe COPD, the proportions of patients who had
undergone spirometry, and the proportions of patients
categorised as having mild, moderate and severe airflow
obstruction. Secondly, a smaller sub-sample of notes was
examined in order to assess the quality of spirometry.
The first-level sample was constructed as follows. In an
initial pilot practice we randomly selected approximately
50% (161) of the patients with COPD, followed by two
further pilot practices in which 90% (140 and 125) of
patients were randomly selected. Thereafter, in the main
study, we took random samples of 100 patients with
COPD from each practice (unless there were fewer than
100 patients with COPD, in which case all patients on the
practice COPD register were included). The smaller sec-
ond-level sub-sample of patients contained a randomly
selected subset of one in five patients from the first-level
sample, stratified by practice, with a minimum of twenty
patients from any single practice. For both levels of the
sample, patients were selected using computer generated
random numbers.
Data collection
Data were obtained in the period between October 2006
and February 2007 by a small team of specialist nurses
who visited each practice and searched paper records by
hand, and computer records electronically.
Analysis
From the larger first-level sample of notes we determined
the proportion of patients with COPD who had had
spirometry (ever, and in the previous 12 months), and the
proportion of patients who had had their airflow obstruc-
tion categorised as mild, moderate or severe. We also used
the most recent FEV1 results in the notes to categorise
patients according to NICE criteria for categorising airflow
obstruction (FEV1 50–80% of predicted, mild obstruc-
tion; FEV1 30–49% predicted, moderate obstruction;
FEV1 < 30% predicted, severe obstruction)[1]. We com-
pared categorisation on this basis with the clinical catego-
risation recorded in the notes. Cohen's Kappa statistic was
used to assess agreement.
From the one in five randomly selected sub-sample of
notes we determined the proportion of patients in whose
notes there was evidence that spirometry had been carried
out to British Thoracic Society (BTS) standards (three con-
sistent readings of which two were within 5% or 100
mls)[7]. We excluded cases where the most recent spirom-
etry had been performed in secondary care, and where the
trace had faded such that the quality of the spirometry was
indeterminate.
We recorded practice level achievement against the COPD
QOF indicators (COPD 1, 8, 9, 10 and 11) for the 38 prac-
tices in 2006–07 (see table 1). We examined for an asso-
ciation between the quality of spirometry as measured by
adherence to BTS guidelines for spirometry and QOF
achievement against the two spirometry related indica-
tors, COPD 9 and COPD 10, using Spearman's correlation
coefficient.Page 2 of 5
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practice level stratified sampling method[8], and confi-
dence intervals for proportions were calculated using the
Normal approximation. Bracketed intervals following
point estimates are 95% confidence intervals unless stated
otherwise. All analyses were carried out in R 2.9.0[9].
Ethics approval
Ethics approval for this study was provided by Rotherham
NHS Research Ethics Committee (ref number 06/
Q230636).
Results
At the time of the study practice list sizes ranged from
1,323 to 20,668. The crude prevalence of COPD ranged
from 1.0% to 4.0% of the practice population, and the
number of people on the QOF COPD register at each
practice ranged from 22 to 395. Across the PCT the total
number of COPD patients was 5,649, representing a
mean PCT prevalence of 2.2%. This is approximately 50%
higher than the crude prevalence in England of 1.4%[5].
3,217 (57%) sets of notes were selected for the first-level
sample. The mean age of those sampled was 69 years (sd
= 11 years) for both males and females. The current smok-
ing prevalence was 31% (95% CI 29%–34%) in men, and
39% (95% CI 37%–41%) in women.
In 81% (80%–82%) of cases we found that spirometry
had been performed at some point in the past, and in 50%
(49%–51%) this was within the previous 12 months. Dis-
ease severity had been categorised by a clinician in 53%
(51%–54%) of notes. Of those categorised, 45% (42%–
48%) were categorised as mild, 35% (32%–38%) as mod-
erate and 19% (16%–21%) as severe.
In 42% (40%–43%) of cases both a clinician categorisa-
tion of COPD and a spirometry result were recorded in the
notes. When we categorised airflow obstruction according
to the most recent FEV1 (% predicted) result, we found
that patients tended to be categorised clinically as having
either the same or more severe disease than was suggested
by their most recent spirometry result (table 2). Agree-
ment between clinician recorded disease severity and air-
way obstruction according to the spirometry results was
low (Cohen's kappa = 0.34, 0.30 – 0.38). Approximately
12% of patients had spirometry results that did not appear
to be consistent with a diagnosis of COPD.
A random sample of 761 (13.5%) sets of notes, stratified
by practice, was selected for more detailed analysis. The
most recent spirometry had been conducted in secondary
care in 38 (5%) cases. Where spirometry had been per-
formed in the practice, BTS standards (three readings, two
of which were within 5% or 100 mls) were met in 31%
(27%–35%) of cases. We excluded four (0.5%) cases
where the spirometry trace had faded or was otherwise
Table 1: QOF COPD indicators (2006–7)
Indicator Details Points available
COPD 1 The practice can produce a register of patients with COPD 3
COPD 8 The percentage of patients with COPD who have had influenza immunisation in the preceding 1 September to 31 
March
6
COPD 9 The percentage of all patients with COPD in whom diagnosis has been confirmed by spirometry including 
reversibility testing
10
COPD 10 The percentage of patients with COPD with a record of FeV1 in the previous 15 months 7
COPD 11 The percentage of patients with COPD receiving inhaled treatment in whom there is a record that inhaler 
technique has been checked in the previous 15 months
7
Notes: indicators numbered COPD 2–7 were included in previous years' contracts and are now redundant. Points are worth approximately £124 
for an average practice.
Table 2: Agreement between COPD categorisation by spirometry, and COPD categorisation by clinician
COPD category by FEV1 (% predicted) result
Clinician categorisation of COPD Normal Mild Moderate Severe Total
Normal 0 0 0 0 0
Mild 140 470 50 13 673
Moderate 17 218 235 13 483
Severe 5 23 105 97 230
Total 162 711 390 123 1386Page 3 of 5
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cases in one practice, to 0% in seven practices.
Overall, the 38 Rotherham practices achieved 94.5%
(range 42.7% to 100%) of the QOF points available in the
COPD domain in 2006–7, slightly lower than the
national average achievement of 96.0% (table 3). At a
practice level there was no correlation between the quality
of spirometry as measured by adherence to the BTS stand-
ard (three readings, of which two were within 5% or 100
ml) and QOF achievement for spirometry as measured by
either QOF indicator COPD 9 (Spearman's correlation
coefficient = -0.11, p = 0.51), or indicator COPD 10
(Spearman's correlation coefficient = 0.01, p = 0.94).
Discussion
Main findings
In 2006–7, practices in Rotherham achieved highly
against the two QOF indicators that relate to spirometry,
with the COPD 9 criteria met for 97.4% of the patients on
COPD registers, and the COPD 10 criteria met for 89.5%
of patients. However, in only 31% (95% CI 27%–35%) of
cases were we able to find evidence of spirometry to BTS
standards, and 12% of patients on COPD registers had
FEV1 (% predicted) results recorded that did not support
the diagnosis of COPD. There was no correlation at prac-
tice level between the QOF achievement against the two
spirometry related indicators, and the quality of that
spirometry. When we compared clinical categorisation of
COPD severity with airflow obstruction severity we found
that patients tended to be categorised clinically as having
either the same or a higher severity of COPD than their
category of airways obstruction severity.
Limitations
Our assessment of quality of care was based on informa-
tion that we were able to extract from the paper and elec-
tronic records held by the practices. Incompleteness or
inaccuracy in the recording of care by a practice would
limit the validity of our assessment of quality. It is possi-
ble that records were complete and accurate, but that we
were unable to extract the information we needed, due,
for example to problems in clinical coding. However, we
would argue that correct coding to allow the easy extrac-
tion of important clinical data is itself good practice, and
related to quality of care.
We found that in 50% (49%–51%) of patients we could
find evidence of spirometry within the previous 12
months. This is rather lower than the reported achieve-
ment of 89.5% against the QOF indicator COPD 10,
which records the proportion of patients in whom there is
a record of FEV1 in the previous 15 months. This could
have been due to the difference in timescales, but also
may be related to the fact that QOF achievement is based
only on the presence of a clinical code attached to the
patient's electronic record, whereas we required evidence
either from a hospital letter that spirometry had been per-
formed, or the presence of the trace or readings.
Our study sample is representative of the population of
people with COPD in only one health district, and the
findings may not therefore be generalisable to the whole
of the UK. It is unlikely, however, that these findings
apply uniquely to Rotherham, an area where COPD care
is high on the agenda of the local health community[10].
There is no single measure of COPD severity, and a
patient's experience of the disease can be heavily influ-
enced by, for example, the frequency of exacerbations,
exercise tolerance, presence of co-morbidities and a range
of psychological factors. Two people with the same degree
of airflow obstruction may therefore experience very dif-
ferent levels of disease severity. It is not surprising then
that we found a difference between clinical categorisation
and airflow severity categorisation, and this confirms that
airflow obstruction severity alone is not necessarily an
adequate measure of COPD severity. However, spirome-
try plays a central role in the diagnosis and management
of COPD and is recommended by NICE[1]. We feel there-
fore that this is strong justification for supporting primary
care clinicians to conduct spirometry to nationally agreed
standards.
Table 3: Overall QOF achievement against COPD indicators for Rotherham and England.
Indicator Mean achievement, points per practice, as percentage of points available
Rotherham (practice range in brackets) England
COPD 1 100% 99.7%
COPD 8 99.1% (75.7% to 100%) 98.4%
COPD 9 97.4% (28.4% to 100%) 97.4%
COPD 10 89.5% (16.7% to 100%) 93.0%
COPD 11 89.0% (43.3% to 100%) 93.5%
Overall 94.5% (42.7% to 100%) 96.0%Page 4 of 5
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The relationship between QOF and spirometry has not
been evaluated previously, though there are studies that
have examined the relationship between QOF and other
aspects of quality of care. A small study in two general
practices in South East England found no relationship
between QOF achievement and adherence to guidelines
for people with stroke[11]. Poor data quality was cited as
the probable reason for the apparent lack of quality of
care. A larger study across two PCTs found that the associ-
ations between QOF and health outcomes (hospital
admissions for a range of conditions and all-cause mortal-
ity) were small and inconsistent[12]. This finding may not
be surprising given the relatively weak association
between quality of care and outcomes, even after risk
adjustment, due to the many other factors that influence
outcomes[13].
QOF has been a step forward towards the systematic pop-
ulation wide management of COPD because, for the first
time, practices hold registers of all their patients diag-
nosed with COPD. However, this study has highlighted a
number of worrying results. The QOF contract represents
a substantial investment in UK general practice and has
caused significant shifts in priorities in primary care[14].
The recording of spirometry data in general practice
increased markedly after the introduction of the 2003
QOF contract and 2004 NICE guidance (from 18% to
62% according to one large study)[15]. However, the
value of this increase in recording to patients will only be
maximised if the spirometry itself is carried to high quality
standards.
Conclusion
Our results suggest that the current Quality and Outcomes
Framework contract measures the quantity, but not neces-
sarily the quality of spirometry, and as such represents a
lost opportunity to further improve COPD care. Possible
solutions could be to revise the QOF criteria to include
more explicit quality linked indicators, or alternatively, to
give a much greater emphasis to alternative mechanisms
of quality improvement such as clinical audit.
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